Evidence map›Paper›PMID 36759652›Full record

ArticleScientific reports2023

Assessing the reproducibility and up-scaling of the synthesis of Er,Yb-doped NaYF

Elina Andresen, Fahima Islam, Carsten Prinz, Philipp Gehrmann, Kai Licha, Janina Roik, Sebastian Recknagel, Ute Resch-Genger

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Enhanced Single-Particle Upconversion Imaging via Energy Migration Boosting.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  5. Article
  6. Sub-10 nm YbRSC advances · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elina AndresenDivision Biophotonics, Federal Institute of Materials Research and Testing (BAM), Richard-Willstaetter-Str. 11, 12489, Berlin, Germany. elina.andresen@bam.de.
Fahima IslamDivision Biophotonics, Federal Institute of Materials Research and Testing (BAM), Richard-Willstaetter-Str. 11, 12489, Berlin, Germany.
Carsten PrinzDivision Structure Analytics, Federal Institute of Materials Research and Testing (BAM), Richard-Willstätter-Str. 11, 12489, Berlin, Germany.
Philipp GehrmannFEW Chemicals GmbH, Technikumstraße 1, 06766, Bitterfeld-Wolfen, Germany.
Kai LichaFEW Chemicals GmbH, Technikumstraße 1, 06766, Bitterfeld-Wolfen, Germany.
Janina RoikDivision Inorganic Reference Materials, Federal Institute of Materials Research and Testing (BAM), Richard-Willstaetter-Str. 11, 12489, Berlin, Germany.
Sebastian RecknagelDivision Inorganic Reference Materials, Federal Institute of Materials Research and Testing (BAM), Richard-Willstaetter-Str. 11, 12489, Berlin, Germany.
Ute Resch-GengerDivision Biophotonics, Federal Institute of Materials Research and Testing (BAM), Richard-Willstaetter-Str. 11, 12489, Berlin, Germany. ute.resch@bam.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lanthanide-based, spectrally shifting, and multi-color luminescent upconverting nanoparticles (UCNPs) have received much attention in the last decades because of their applicability as reporter for bioimaging, super-resolution microscopy, and sensing as well as barcoding and anti-counterfeiting tags. A prerequisite for the broad application of UCNPs in areas such as sensing and encoding are simple, robust, and easily upscalable synthesis protocols that yield large quantities of UCNPs with sizes of 20 nm or more with precisely controlled and tunable physicochemical properties from low-cost reagents with a high reproducibility. In this context, we studied the reproducibility, robustness, and upscalability of the synthesis of β-NaYF

Identifiers

PMID36759652
PMCPMC9911732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.